Biogen (BIIB)
Biogen (BIIB) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- BIIB last traded at $249.28 on 2026-11-20, 0.87% for the session.
- Biogen: market cap $36.85B, P/E 106.0, revenue $10.30B over the last four quarters, next earnings 2027-02-05.
- Over the past year BIIB returned 48.44%, with a year-to-date return of 41.64%.